Share Article
Michael Harrison joins Urenco as Non-Executive Director
18 October 2021 Global NewsUrenco Limited is pleased to announce the appointment of Michael Harrison as a new UK appointed Non-Executive Director.
Michael succeeds Richard Nourse, who served on Urenco’s Board for 12 years.
The Board of Urenco greatly appreciates and thanks Richard for the contribution that he has made to Urenco during a period of significant growth and consolidation of the company’s position in the enrichment market.
Michael qualified as a Chartered Accountant with PricewaterhouseCoopers (PWC). He was Executive Director at Caliburn, a leading independent investment bank in Australia and Director at Credit Suisse First Boston/BZW.
He has held a number of executive roles in UK Government, including his current position as Head of Governance/Portfolio at UK Government Investments (part of HM Treasury). He is responsible for the commercial management of Government owned assets including the British Business Bank and Channel 4.
Michael is currently a Non-Executive Director of Network Rail and has been a Non-Executive Director of several organisations including Porton Biopharma, Ordnance Survey, the Met Office and Working Links, and served on the investment committee for a charity for civil servants.
Stephen Billingham, Urenco Chairman, said: “I am pleased to welcome Michael to our Board. He brings a wealth of experience across sectors and a deep understanding of businesses that operate at the public/private sector interface.”
Share Article
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries